MRI新出现特征动态变化可提高小复发性肝细胞癌诊断敏感性
回顾性分析398例根治性切除术后患者460个新发肝脏结节，其中351个（76.3%）证实为复发性肝细胞癌。新出现的MRI特征（包括新发动脉期高强化、廓清、强化包膜、阈值增长、轻中度T2高信号、弥散受限和T1低信号）诊断敏感性94.9%，显著高于阈值增长（60.6%）和LI-RADS 5（45.6%），特异性相当（96.3% vs 98.2% vs 98.2%）。弥散受限（OR 2.18）和T1低信号（OR 20.48）是独立预测因子。
要点
- 新出现MRI特征诊断小复发性HCC敏感性94.9%，显著优于阈值增长和LI-RADS 5。
- 弥散受限（OR 2.18）和T1低信号（OR 20.48）是独立预测因子。
- 随访中应关注新出现的MRI特征而非仅依赖LI-RADS分类。
核心结论
- 新出现的MRI特征对早期诊断复发性HCC的敏感性高于阈值增长和LI-RADS 5分类，同时保持高特异性。
研究设计与样本
- 以病理或临床随访确认复发HCC为参考标准，采用logistic回归分析初始检测时与复发HCC独立相关的影像特征。
- 比较新出现MRI特征、3个月随访MRI阈值增长和LI-RADS分类的诊断性能。
关键影像表现/征象
- 新出现MRI特征包括新发动脉期高强化、廓清、强化「capsule」、阈值增长、轻中度T2高信号、弥散受限和T1低信号。
- 弥散受限和T1低信号是初始检测时复发的独立预测因子。
诊断标准与关键数值
- 新出现MRI特征诊断复发性HCC敏感性94.9%，特异性96.3%，AUC 0.96（排除LI-RADS 5结节后AUC 0.94）。
- 阈值增长单独诊断敏感性60.6%；LI-RADS 5分类敏感性45.6%，特异性98.2%。
- 新出现特征与阈值增长和LI-RADS 5的敏感性比较P均<0.001，特异性比较P>0.99。
- 弥散受限OR 2.18（95%CI 1.20-3.95，P=0.01），T1低信号OR 20.48（95%CI 11.53-36.36，P<0.001）。
临床应用与阅片要点
- 术后随访MRI发现新发不典型结节时，应重点评估是否出现新发动脉期高强化、廓清、强化包膜、弥散受限和T1低信号等特征。
- 对于LI-RADS未达5类的小结节，结合新出现MRI特征可提高复发性HCC的检出敏感性而不明显降低特异性。
- 注意阈值增长和LI-RADS 5分类单独应用时敏感性较低，可能漏诊小复发病灶。
局限性
- 回顾性单中心研究，样本来自特定时间段的手术患者，结论需外部验证。
- 参考标准未明确全部为病理证实，部分可能依赖临床随访。
以上解读依据论文摘要（全文未开放获取或许可不允许翻译转载）。
英文原文（摘要）· 点击展开
AIM: To establish improved diagnostic criteria for small recurrent hepatocellular carcinoma (HCC) (<20 mm) presenting with indeterminate findings on postoperative surveillance magnetic resonance imaging (MRI).
MATERIALS AND METHODS: Patients who underwent curative resection for primary HCC between January and December 2018 were retrospectively reviewed. Newly detected hepatic nodules with atypical imaging features on surveillance MRI were included. Logistic regression analyses were performed to identify imaging features independently associated with recurrent HCC at the time of initial detection. The diagnostic performance of newly emerged MRI features (newly emerged arterial phase hyperenhancement, washout, enhancing 'capsule', threshold growth, mild-to-moderate T2 hyperintensity, restricted diffusion, and T1 hypointensity), threshold growth on 3-month follow-up MRI, and the liver imaging reporting and data system (LI-RADS) category were assessed and compared.
RESULTS: A total of 398 patients with 460 newly detected nodules were analysed, of which 351 (76.3%) were confirmed as recurrent HCC. Restricted diffusion (odds ratio [OR], 2.18; 95% confidence interval [CI], 1.20-3.95; P = 0.01) and T1 hypointensity (OR, 20.48; 95% CI, 11.53-36.36; P < 0.001) were independent predictors of recurrence at initial detection. Compared with threshold growth alone (sensitivity, 60.6%) and LI-RADS 5 (sensitivity, 45.6%), newly emerged MRI features demonstrated significantly higher sensitivity (94.9%; P < 0.001 for both) while maintaining comparable specificity (96.3% vs. 98.2% vs. 98.2%; P > 0.99). The area under the receiver operating characteristic (ROC) curve for newly emerged features was 0.96 (0.94 after excluding LI-RADS 5 nodules).
CONCLUSION: Newly emerged MRI features offer higher sensitivity than threshold growth and LI-RADS 5 categorisation, while maintaining high specificity for the early diagnosis of recurrent HCC.
引用
- Chen J, Chen X, Wang W, et al. Dynamic changes in magnetic resonance imaging (MRI) features improve sensitivity for diagnosing small recurrent hepatocellular carcinoma after resection. Clin Radiol. 2026. PMID: 42241746. doi:10.1016/j.crad.2026.107382
供执业医师工作参考，不替代临床判断；数值与分级以指南原文为准。